{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "02/17/2021",
      "package_ndc": "0068-0597-01",
      "generic_name": "Rifampin Injection",
      "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Rifampin%20Injection&st=d",
      "contact_info": "800-633-1610",
      "availability": "Unavailable",
      "related_info": "Discontinuation of the manufacture of the drug",
      "openfda": {
        "application_number": [
          "NDA050627"
        ],
        "brand_name": [
          "RIFADIN IV"
        ],
        "generic_name": [
          "RIFAMPIN"
        ],
        "manufacturer_name": [
          "Sanofi-Aventis U.S. LLC"
        ],
        "product_ndc": [
          "0068-0597"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "RIFAMPIN"
        ],
        "rxcui": [
          "207436",
          "312821"
        ],
        "spl_id": [
          "82e2bbb1-cc73-4fbd-8d85-610634876355"
        ],
        "spl_set_id": [
          "036ab68e-5085-4edc-bd83-784b43d64eab"
        ],
        "package_ndc": [
          "0068-0597-01"
        ],
        "nui": [
          "N0000175500",
          "M0019113"
        ],
        "pharm_class_epc": [
          "Rifamycin Antibacterial [EPC]"
        ],
        "pharm_class_cs": [
          "Rifamycins [CS]"
        ],
        "unii": [
          "VJT6J7R4TR"
        ]
      },
      "update_date": "06/22/2026",
      "therapeutic_category": [
        "Anti-Infective"
      ],
      "dosage_form": "Injection",
      "presentation": "Rifadin, Injection, 600 mg (NDC 0068-0597-01)",
      "company_name": "Sanofi-Aventis U.S. LLC",
      "shortage_reason": "Discontinuation of the manufacture of the drug",
      "status": "Current"
    }
  ]
}